drugset / Trial / NCT02034890

Intravesical Instillation of Hyaluronic Acid to Decrease Incidence of Urinary Tract Infection

NCT02034890

Phase 4 Withdrawn Rabin Medical Center
Non-randomizedSingle-groupOpen-labelPrevention

Summary

Prospective trial which includes instillation of intravesical hyaluronic acid in an attempt to reduce the incidence of urinary tract infections in patients after orthotopic neobladder reconstruction.

Timeline

Start
2015-07
Primary completion
2017-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Hyaluronic Acid Other / unclassified 40 mg Other